| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $105.4M | — | +60.1% |
| Cost of Revenue | $9.8M | — | +10.8% |
| R&D Expense | $30.6M | — | +74.6% |
| SG&A Expense | $74.1M | — | +15.7% |
| Operating Income | -$9.1M | — | +62.9% |
| Income Tax | $93K | — | -66.7% |
| Net Income | -$11.3M | — | +54.9% |
| EPS (Basic) | -$0.09 | — | +55.0% |
| EPS (Diluted) | -$0.09 | — | +55.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.8M | -19.0% | -34.5% |
| Accounts Receivable | $144.4M | -1.3% | +69.0% |
| Inventory | $37.4M | +65.2% | +125.1% |
| Current Assets | $438.1M | +6.5% | +35.3% |
| Total Assets | $460.0M | +6.2% | +33.7% |
| Current Liabilities | $163.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.2M | — | +107.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$11.3M | — | -196.4% |
| Financing Cash Flow | $1.1M | — | +170.1% |
| Free Cash Flow | $2.2M | — | +107.2% |
| +79.1% |
| Long-term Debt | $109.4M | +0.4% | +1.7% |
| Total Liabilities | $270.4M | +11.0% | +34.2% |
| Stockholders' Equity | $189.6M | +0.1% | +32.9% |